[Abstract] Interferon regulatory transcription factor 3 (IRF3) is a transcription factor that upon activation by virus infection promotes the synthesis of antiviral genes, such as the interferons (Hiscott, 2007) . In addition to inducing genes, IRF3 triggers antiviral apoptosis by RIG-I-like receptor-induced IRF3
RIPA, IRF3 interacts with BCL-2-Associated X protein (BAX), a pro-apoptotic factor (Chattopadhyay et al., 2010) . Upon binding to BAX, IRF3 translocates to the mitochondria, and initiates a signaling cascade that ultimately promotes apoptosis (Chattopadhyay et al., 2010) . In the absence of IRF3 or other components of RIPA, the cells establish viral persistence when infected with Sendai virus (SeV) (Peters et al., 2008; Chattopadhyay et al., 2013) . These persistent cell lines are useful for studying the full antiviral mechanisms of cells because the cells do not undergo apoptotic cell death. In the current protocol, we provide a detailed method to create a SeV persistent human cell line, which are defective in IRF3
expression. Viral persistence is common for many viruses, which efficiently antagonize the cell death pathways of the infected cells. An in vitro approach to study persistently infected cells will reveal ways to avoid the establishment of viral persistence. It will also be evaluated in future whether the absence of RIPA can be used as a tool to generate persistently infected cells using viruses of different lifestyles. 4. Electrophorese the proteins at 100 V for 2 h, or until adequate separation of proteins in the 10-100 kDa region is achieved.
Materials and Reagents
5. Transfer proteins onto a PVDF membrane using a Bio-Rad semi-dry transfer apparatus at 0.06 mA for 1.5 h.
6. Block the membrane in TBST containing 5% nonfat dry milk on a rocker at room temperature for 30 min.
7. Add the anti-Sendai Virus C antibody at 1:5,000 dilution in blocking buffer. Incubate on a rocker at room temperature for 1 h or 12-16 h at 4 °C.
8. Wash the membrane three times in TBST, and add the secondary (HRP-conjugated) antibody, diluted to 1:5,000 dilution in blocking buffer, incubating for 1 h at room temperature.
9. Wash the membrane three times in TBST and incubate in ECL solution for 1-3 min.
10. Develop on autoradiograph film using an autoradiograph film processor.
C. Quantification of infectious virus particles in persistently infected cells
The infectious SeV titers in the culture supernatants were determined by previously described procedure (Peters et al., 2008) and was represented as pfu/ml. Briefly, the following procedure is performed:
1. Seed LLC-MK2 cells in 6-well plate at 100,000 cells per well in Medium 199 and allow the cells to become confluent (in about three days).
2. The culture supernatants from the persistently infected cell lines are serial diluted and then used to infect confluent LLC-MK2 monolayer, using the virus infection protocol (as described in Procedure A). 
Data analysis
To confirm that viral persistence has been achieved, a few relatively simple assays may be performed. Sendai virus expresses a non-structural protein (C), also known as SeV C, which can be detected by Western blotting of the persistently infected P2.1 cells, the procedure for which is outlined in the previous section. To confirm the presence, or rather, the absence of clearance of SeV www.bio-protocol.org/e2512 
Notes
Western blot for detection of SeV C protein should be carefully evaluated because the antibody also cross reacts with other viral and cellular proteins which are of similar sizes. Careful separation of these proteins on a 20% SDS gels will facilitate the analyses (Figure 3) . 
